AlzeCure presents novel Alzstatin data at the 11th Symposium on Pharmaceutical Profiling meeting
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule drug candidates for diseases affecting the central nervous system, with projects in